Cash Flow Statement
Growth Metrics

Opko Health (OPK) Shares Outstanding (Weighted Average) (2016 - 2026)

Opko Health filings provide 17 years of Shares Outstanding (Weighted Average) readings, the most recent being $758.9 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 13.0% to $758.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $758.9 million, a 13.0% increase, with the full-year FY2025 number at $751.1 million, up 8.23% from a year prior.
  • Shares Outstanding (Weighted Average) hit $758.9 million in Q1 2026 for Opko Health, up from $751.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $788.0 million in Q2 2025 to a low of $660.3 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $750.4 million (2022), compared with a mean of $728.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 16.03% in 2022 and later decreased 7.68% in 2024.
  • Opko Health's Shares Outstanding (Weighted Average) stood at $719.1 million in 2022, then increased by 4.55% to $751.8 million in 2023, then decreased by 7.68% to $694.0 million in 2024, then grew by 8.23% to $751.1 million in 2025, then increased by 1.03% to $758.9 million in 2026.
  • The last three reported values for Shares Outstanding (Weighted Average) were $758.9 million (Q1 2026), $751.1 million (Q4 2025), and $777.2 million (Q3 2025) per Business Quant data.